We are live on ! Find out more
CII

CR Intrinsic Investors Portfolio holdings

AUM $2.67B
1-Year Est. Return 28.43%
This Fund
S&P 500
This Quarter Est. Return
+1.99%
1 Year Est. Return
+28.43%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.67B
AUM Growth
+$363M
Cap. Flow
+$333M
Cap. Flow %
12.49%
Top 10 Hldgs %
15.66%
Holding
393
New
127
Increased
67
Reduced
60
Closed
135

Top Buys

Rank Stock Value
1
CI icon
Cigna
CI
+$41.2M
2
ISRG icon
Intuitive Surgical
ISRG
+$40.3M
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$37M
4
CVSA
Covista Inc
CVSA
+$36.7M
5
BSX icon
Boston Scientific
BSX
+$26.3M

Top Sells

Rank Stock Value
1
CCI icon
Crown Castle
CCI
+$38.6M
2
CHTR icon
Charter Communications
CHTR
+$38.3M
3
GT icon
Goodyear
GT
+$34.3M
4
OC icon
Owens Corning
OC
+$29.8M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$23.4M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 26.06%
2 Healthcare 17.09%
3 Industrials 9.3%
4 Consumer Staples 5.77%
5 Technology 5.1%

No holdings matched the selected filter criteria.

12 13 14 15 16

Similar funds

SCM
Sigma Capital Management Stamford, Connecticut $1.95B AUM 42.85% 1-Year Est. Return
SZC
Sleep, Zakaria & Co London, United Kingdom $1.5B AUM 22.67% 1-Year Est. Return
RM
RTLC Management Birmingham, Michigan $3.97B AUM
HOAM
Halcyon Offshore Asset Management New York $1.02B AUM 37.23% 1-Year Est. Return
SC
Sureview Capital Greenwich, Connecticut $229M AUM 50.34% 1-Year Est. Return
G
GlobalBridge Minneapolis, Minnesota $215M AUM 22.99% 1-Year Est. Return
TT
Tower Trust Fort Wayne, Indiana $159M AUM 18.24% 1-Year Est. Return
IPRC
Indices-Pac Research Corporation Montvale, New Jersey $156M AUM 16.72% 1-Year Est. Return

CR Intrinsic Investors's Q1 2014 Portfolio in Review

As of Q1 2014, CR Intrinsic Investors held 393 positions worth $2.67B, up 16% from $2.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

CR Intrinsic Investors deployed $333M of net new capital in Q1 2014, opening 127 new positions and adding to 67 existing holdings. Its largest new stake was Cigna: 500,000 shares worth $41.9M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 26% of assets, down from 30% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Goodyear, an estimated $34.3M trimmed.

  • CR Intrinsic Investors's largest Q1 2014 buy was Cigna: 500,000 shares worth $41.9M.
  • CR Intrinsic Investors added most to Boston Scientific in Q1 2014, an estimated $26.3M increase.
  • CR Intrinsic Investors's biggest Q1 2014 reduction was Goodyear, cutting an estimated $34.3M.
  • CR Intrinsic Investors fully exited Crown Castle in Q1 2014, selling an estimated $38.6M.
  • CR Intrinsic Investors's ten largest holdings make up 16% of its $2.67B portfolio in Q1 2014.
  • CR Intrinsic Investors opened 127 new positions and closed 135 in Q1 2014.
  • CR Intrinsic Investors's portfolio value rose 16% quarter-over-quarter to $2.67B.

Based on CR Intrinsic Investors's 13F filing for Q1 2014, filed 15 May 2014.